Latest
How Tariffs Impact Access to Medicines
Import duties on pharmaceutical manufacturing inputs such as APIs cost patients US$1.2bn in the US and US$1.1bn in the EU, find Philipp Lamprecht and Matthias Bauer in this new Geneva Network working paper.
Why waiving intellectual property rights for Covid vaccines is wrong
The UK, EU and other allies should speak out against the badly thought out proposal before the WTO.
Featured
How Tariffs Impact Access to Medicines
Import duties on pharmaceutical manufacturing inputs such as APIs cost patients US$1.2bn in the US and US$1.1bn in the EU, find Philipp Lamprecht and Matthias Bauer in this new Geneva Network working paper.
Una declaración conjunta sobre la importancia de los DPI para la producción a escala de vacunas anti-covid y la preparación para futuras pandemias
Somos una coalición informal de organizaciones de la sociedad civil que cree que la colaboración...
A joint declaration on the importance of IPRs to Covid vaccine manufacturing scale-up and future pandemic preparedness
An international coalition of think tanks calls on governments to reject a proposal at the WTO to waive intellectual property rights for Covid vaccines
A statement of principles on medicines procurement
This is a statement of principles on medicines procurement collectively issued by think tanks from Argentina, Brazil, Chile, Colombia and Mexico.
Why intellectual property rights matter for COVID-19
The IP system has been crucial in underpinning the research, development and manufacture of vaccines and therapeutics for COVID-19, proving critics of IP wrong at every step of this crisis.
Overcoming obstacles to medicines access
As the 2020 World Health Assembly re-convenes in Geneva, an international coalition of think tanks urges governments to commit to simple reforms to accelerate access to medicines, including those in the process of being developed for Covid-19.
